Trial Profile
A multicentre, retrospective study to evaluate the safety, efficacy, and tolerability of Simeprevir and Sofosbuvir with or without Ribavirin in patients with hepatitis C genotype-1 infection after an orthotopic liver transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 02 Mar 2016 New trial record
- 25 Feb 2016 Results published in the Liver Transplantation